RYAN UNA S

Director at Quince Therapeutics, Inc. · on record since May 26, 2023
Director at Celldex Therapeutics, Inc. · on record since Jan 5, 2006
President & CEO at Celldex Therapeutics, Inc. · on record since Jan 5, 2006
Director at ALBANY MOLECULAR RESEARCH INC · on record since Dec 29, 2006
Director at CORNERSTONE THERAPEUTICS INC · on record since May 8, 2019
Director at RenovoRx, Inc. · on record since Aug 25, 2021

Insider trading activity of RYAN UNA S

Transactions on record: 75; since Sep 19, 2003

Open-market buys: 8; $109.4K

Open-market sells: 0

Companies traded: 5; last filing Oct 2, 2026

Figures computed from official regulatory filings — .

Companies where RYAN UNA S has traded

RenovoRx, Inc.11 tx · $276.5K · Oct 2, 2026
Quince Therapeutics, Inc.3 tx · Jun 6, 2025
CORNERSTONE THERAPEUTICS INC4 tx · $48.9K · Jun 9, 2022
ALBANY MOLECULAR RESEARCH INC42 tx · $1.6M · May 11, 2017
Celldex Therapeutics, Inc.15 tx · $5.1M · Mar 11, 2008

Track record of RYAN UNA S

Statistical track record

Free account

Open-market buys: 8

Last buy: May 13, 2019

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of RYAN UNA S

Co-insiders of RYAN UNA S

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
RenovoRx, Inc.Listing on record	Oct 2, 2026	AwardD (derivative)	55,924	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Jun 24, 2026	Other	6,332	3.95 USD	$25K		SEC
RenovoRx, Inc.Listing on record	Jun 24, 2026	Other	16,206	1.62 USD	$26.3K		SEC
RenovoRx, Inc.Listing on record	Jun 24, 2026	Other	26,838	0.93 USD	$25K		SEC
RenovoRx, Inc.Listing on record	Jun 24, 2026	Other	47,789	4.19 USD	$200.2K	Unusual size	SEC
RenovoRx, Inc.Listing on record	Oct 2, 2025	AwardD (derivative)	47,640	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Jun 6, 2025	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Oct 2, 2024	AwardD (derivative)	25,099	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Oct 2, 2023	AwardD (derivative)	25,099	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	May 26, 2023	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Oct 4, 2022	AwardD (derivative)	25,099	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 9, 2022	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Mar 14, 2022	AwardD (derivative)	4,582	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Oct 5, 2021	AwardD (derivative)	11,154	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 17, 2021	AwardD (derivative)	11,029	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 9, 2020	AwardD (derivative)	11,029	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Mar 12, 2020	Buy	2,875	17.00 USD	$48.9K	conv 84ClusterUnusual size+1	SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	May 11, 2017	Exercise	5,000	14.47 USD	$72.4K		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	May 11, 2017	ExerciseD (derivative)	-5,000	14.47 USD	$72.4K		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Feb 10, 2017	Award	3,802	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Feb 10, 2017	AwardD (derivative)	9,358	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Oct 6, 2016	ExerciseD (derivative)	-5,000	11.83 USD	$59.2K		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Oct 6, 2016	Exercise	5,000	11.83 USD	$59.2K		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Oct 6, 2016	Other	-3,498	16.91 USD	$59.2K	Unusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
RenovoRx, Inc.Listing on record	Oct 2, 2026	AwardD (derivative)	55,924	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Jun 24, 2026	Other	6,332	3.95 USD	$25K		SEC
RenovoRx, Inc.Listing on record	Jun 24, 2026	Other	16,206	1.62 USD	$26.3K		SEC
RenovoRx, Inc.Listing on record	Jun 24, 2026	Other	26,838	0.93 USD	$25K		SEC
RenovoRx, Inc.Listing on record	Jun 24, 2026	Other	47,789	4.19 USD	$200.2K	Unusual size	SEC
RenovoRx, Inc.Listing on record	Oct 2, 2025	AwardD (derivative)	47,640	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Jun 6, 2025	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Oct 2, 2024	AwardD (derivative)	25,099	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Oct 2, 2023	AwardD (derivative)	25,099	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Quince Therapeutics, Inc.Listing on record	May 26, 2023	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Oct 4, 2022	AwardD (derivative)	25,099	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 9, 2022	AwardD (derivative)	27,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Mar 14, 2022	AwardD (derivative)	4,582	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RenovoRx, Inc.Listing on record	Oct 5, 2021	AwardD (derivative)	11,154	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 17, 2021	AwardD (derivative)	11,029	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 9, 2020	AwardD (derivative)	11,029	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Mar 12, 2020	Buy	2,875	17.00 USD	$48.9K	conv 84ClusterUnusual size+1	SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	May 11, 2017	Exercise	5,000	14.47 USD	$72.4K		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	May 11, 2017	ExerciseD (derivative)	-5,000	14.47 USD	$72.4K		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Feb 10, 2017	Award	3,802	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Feb 10, 2017	AwardD (derivative)	9,358	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Oct 6, 2016	ExerciseD (derivative)	-5,000	11.83 USD	$59.2K		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Oct 6, 2016	Exercise	5,000	11.83 USD	$59.2K		SEC
ALBANY MOLECULAR RESEARCH INCListing unverified	Oct 6, 2016	Other	-3,498	16.91 USD	$59.2K	Unusual size	SEC